MENU
+Compare
IVA
Stock ticker: NASDAQ
AS OF
Jun 27 closing price
Price
$3.05
Change
-$0.12 (-3.79%)
Capitalization
429.8M

IVA Inventiva SA Forecast, Technical & Fundamental Analysis

Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation... Show more

IVA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for IVA with price predictions
Jun 27, 2025

Momentum Indicator for IVA turns negative, indicating new downward trend

IVA saw its Momentum Indicator move below the 0 level on June 16, 2025. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 90 similar instances where the indicator turned negative. In of the 90 cases, the stock moved further down in the following days. The odds of a decline are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for IVA turned negative on June 16, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 42 similar instances when the indicator turned negative. In of the 42 cases the stock turned lower in the days that followed. This puts the odds of success at .

IVA moved below its 50-day moving average on June 16, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for IVA crossed bearishly below the 50-day moving average on June 23, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

The Aroon Indicator for IVA entered a downward trend on June 02, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 6 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

IVA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (16.366). P/E Ratio (0.000) is within average values for comparable stocks, (58.189). IVA's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.309). Dividend Yield (0.000) settles around the average of (0.041) among similar stocks. P/S Ratio (16.978) is also within normal values, averaging (252.247).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. IVA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. IVA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
IVA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

IVA is expected to report earnings to fall 66.77% to -60 cents per share on September 25

Inventiva SA IVA Stock Earnings Reports
Q2'25
Est.
$-0.60
Q4'24
Missed
by $1.39
Q3'24
Missed
by $0.20
Q2'24
Missed
by $0.17
Q1'24
Beat
by $0.04
The last earnings report on March 26 showed earnings per share of -182 cents, missing the estimate of -43 cents. With 7.53K shares outstanding, the current market capitalization sits at 429.80M.
A.I. Advisor
published General Information

General Information

a company, which engages in the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis and related diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
50 rue de Dijon
Phone
+33 380447500
Employees
123
Web
https://www.inventivapharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GMOIX30.620.29
+0.96%
GMO International Equity III
HLFMX8.580.05
+0.59%
Harding Loevner Frontier Emerg Mkts Inst
FEYAX28.430.14
+0.49%
Fidelity Advisor Asset Manager 85% A
MCSPX11.650.05
+0.43%
BlackRock Advantage SMID Cap Inv C
FBTAX26.10-0.19
-0.72%
Fidelity Advisor Biotechnology A

IVA and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, IVA has been loosely correlated with TVGN. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if IVA jumps, then TVGN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IVA
1D Price
Change %
IVA100%
-3.65%
TVGN - IVA
36%
Loosely correlated
+5.08%
IVF - IVA
27%
Poorly correlated
-11.75%
CUE - IVA
24%
Poorly correlated
-6.13%
VRCA - IVA
24%
Poorly correlated
-10.28%
IMMP - IVA
23%
Poorly correlated
N/A
More